Sartorius Group

Sartorius Group

Weender Landstrae 94 - 108
37075 Gttingen,Germany

HEK293 Media

HEK293 Media

HEK293 Media & Feed Portfolio

High-Performing Specialty Media and Feed for HEK293 Cell Lines

Growth in gene therapies and viral vector vaccines has increased the demand for robust HEK293 cell lines. Sartorius offers four high-performing suspension HEK media that are designed for use with the high variability of HEK293 cell lines, the versatility of adeno-associated virus and the complexity of viral vector processes. The portfolio also includes a unique feed supplement to boost viral production for gene therapies and vaccines.

Unique HEK Media for Your Unique Cells

HEK Media & Feed Portfolio for Optimized Growth

  • High performance, scalability and quality, ensuring purity and safety of the final product
  • Optimized for transient transfection and infection or stable expression in suspension
  • 100% chemically defined, animal component-free, serum-free
  • Available in liquid and powder formats
  • Requires little or no adaptation from other serum-free media
  • Manufactured under ISO 9001 & ISO 13485 quality standards

Product Enquiry

SSL Secure Connection